EcoDrugPlus

Ensembl ID : ENSSLDG00000005963
Gene Symbol: -
Cross references: -
13 Possible Orthologues:

Ensembl ID : ENSSLDG00000007297
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSSLDG00000010206
Gene Symbol: -
Cross references: -
4 Possible Orthologues:

Ensembl ID : ENSSLDG00000011754
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSSLDG00000011785
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSSLDG00000012168
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSSLDG00000012281
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSSLDG00000003296
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSSLDG00000020642
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSSLDG00000000145
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSSLDG00000022202
Gene Symbol: -
Cross references: -
73 Possible Orthologues:

Ensembl ID : ENSSLDG00000012712
Gene Symbol: -
Cross references: -
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).